News

News

27

2024-05

BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters

May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).

2024-05-27

09

2023-11

Cordis and BrosMed launch ceremony for the localization strategy at CIIE China

The Sixth China International Import Expo (CIIE) kicked off in Shanghai on November 5, 2023, As one of the world’s largest import-themed exhibitions, the CIIE attract a diverse range of exhibitors and enterprises to participate from across the world for global trade and economic cooperation.

2023-11-09

19

2023-10

ESVS 2023 丨Prof. Qizhuang Jin’s team: 12-month results of a peripheral intervention scoring balloon dilatation catheter (BrosMed Tri-Wedge™) in the treatment of stenotic lesions of arteriovenous fistula

The 37th Annual Meeting of the European Society for Vascular Surgery 2023 (ESVS 2023) was successfully held in Belfast, United Kingdom, from September 26 to 29. The ESVS Annual Meeting is globally recognized as one of the most important congresses on vascular surgery, attracting many specialists, professors, and physicians from all over the world every year. During the 4-days event, a wide range of educational webinars, interactive case discussions and hands-on workshops were organized to provide participants with a wide range of advanced training opportunities from the 5 academy areas: aortic, carotid, PAD, vascular access and venous.

2023-10-19

21

2023-06

BrosMed Medical Earns MDSAP Certification

Dongguan-June 21, 2023-Today BrosMed announced that it has earned the Medical Device Single Audit Program (MDSAP) certification, indicating that the single regulatory audit to BrosMed satisfies the requirements of multiple regulatory jurisdictions participating in the program.

2023-06-21

12

2023-04

BrosMed’s POT™ NC PTCA Balloon Dilatation Catheter Receives FDA 510(k) Clearance

April 12, 2023—BrosMed Medical has received FDA 510(k) clearance for the POT™ NC PTCA Balloon Dilatation Catheter, which is the world’s first dedicated balloon for proximal optimization technique (POT) and distal optimization technique (DOT) in bifurcation stenting. With this certification, a specialized tool in the treatment of precise PCI for bifurcation lesions is available to US physicians.

2023-04-12

21

2023-03

BrosMed Announced CE MDR Approval of Tiche™ 0.035”High Pressure PTA Balloon Dilatation Catheter

March 21, 2023- BrosMed today announced that it receives European Medical Device Regulation (MDR) certification for Tiche™ 0.035” High Pressure PTA Balloon Dilatation Catheter which is designed for the treatment of severely calcified peripheral vascular disease and challenging AV cases. It is the first MDR certificate of BrosMed and also a successful conformity assessment which set a precedent for the future.

2023-03-21

29

2022-11

BrosMed Medical Announces Japanese Approval and Launch of Rokku Exchange Device In Japan Market

Guangdong, China [Nov. 24, 2022] – BrosMed Medical announced its exchange device has received the Japan PMDA approval.

2022-11-29

All
  • All
  • Product Management
  • News
  • Introduction
  • Enterprise outlets
  • FAQ
  • Enterprise Video
  • Enterprise Atlas